The survival time of cholangiocarcinoma patients varies depending on the location of the lesion, the stage of the cancer, and the presence of adjacent or distant metastases. Cholangiocarcinoma is a malignant tumor originating from the bile duct epithelium, which can occur in various parts of the intrahepatic bile duct, hilar bile duct and lower bile duct. Early stage cholangiocarcinoma mainly manifests as abdominal pain, jaundice, abdominal distension, etc. Through radical surgery and post-operative radiotherapy, patients have the possibility to be cured. Late stage bile duct cancer often combines multiple symptoms, due to the presence of adjacent organs and distant metastases. Patients are unable to undergo radical surgery and can only take palliative treatment, so the 5-year survival rate is low and the prognosis is poor. The 5-year survival rate of hepatoportal cholangiocarcinoma is about 30%, which is higher than that of lower and middle bile duct cancer. Cholangiocarcinoma needs early detection and treatment. Patients should maintain an optimistic and positive attitude to participate in treatment, and family members should also do a good job in nursing and giving patients confidence.